Earnings Feed
Start Free
Home/Filings/3/0000899243-20-011680
3//SEC Filing

NBVM GP, LLC 3

Accession 0000899243-20-011680

CIK 0001327273other
View on SEC.govCompany Profile

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 7:23 PM ET

Size

47.7 KB

Accession

0000899243-20-011680

Insider Transaction Report

Form 3
Period: 2020-04-30
Lyra Therapeutics, Inc.LYRA
NBVM GP, LLC
10% Owner
Holdings

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (84,963 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (53,236 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (90,613 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (57,868 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (34,408 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (21,060 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (13,449 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (33,572 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (50,027 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (56,519 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (46,489 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (65,208 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (69,364 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (47,783 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (88,500 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (16,455 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (32,066 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (15,717 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (70,200 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (44,832 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (10,322 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (43,377 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (60,573 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (133,039 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (94,849 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (108,614 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (44,413 underlying)
NORTH BRIDGE VENTURE PARTNERS V A LP
10% Owner
Holdings

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (33,572 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (15,717 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (47,783 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (94,849 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (60,573 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (65,208 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (70,200 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (34,408 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (44,832 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (13,449 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (50,027 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (46,489 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (16,455 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (32,066 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (88,500 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (43,377 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (56,519 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (133,039 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (84,963 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (108,614 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (53,236 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (69,364 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (90,613 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (44,413 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (57,868 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (21,060 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (10,322 underlying)
NORTH BRIDGE VENTURE PARTNERS V-B LP
10% Owner
Holdings

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (50,027 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (15,717 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (43,377 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (65,208 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (88,500 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (56,519 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (57,868 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (34,408 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (16,455 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (33,572 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (32,066 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (60,573 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (53,236 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (69,364 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (90,613 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (44,413 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (70,200 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (44,832 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (21,060 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (10,322 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (13,449 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (47,783 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (94,849 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (46,489 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (133,039 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (84,963 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (108,614 underlying)
DAMORE RICHARD A
10% Owner
Holdings

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (33,572 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (16,455 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (46,489 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (53,236 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (90,613 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (44,413 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (57,868 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (70,200 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (44,832 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (34,408 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (10,322 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (50,027 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (32,066 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (15,717 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (47,783 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (88,500 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (43,377 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (56,519 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (94,849 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (60,573 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (133,039 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (65,208 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (84,963 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (108,614 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (69,364 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (21,060 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (13,449 underlying)
North Bridge Venture Partners VI L P
10% Owner
Holdings

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (133,039 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (53,236 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (32,066 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (33,572 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (16,455 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (84,963 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (50,027 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (15,717 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (88,500 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (47,783 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (43,377 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (56,519 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (94,849 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (46,489 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (60,573 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (65,208 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (108,614 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (69,364 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (90,613 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (57,868 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (34,408 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (21,060 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (13,449 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (44,413 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (70,200 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (44,832 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (10,322 underlying)
North Bridge Venture Management VI, L.P.
10% Owner
Holdings

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (69,364 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (44,413 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (44,832 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (16,455 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (65,208 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (53,236 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (33,572 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (94,849 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (50,027 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (15,717 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (88,500 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (60,573 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (133,039 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (84,963 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (56,519 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (108,614 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (47,783 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (43,377 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (46,489 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (32,066 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (90,613 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (57,868 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (70,200 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (34,408 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (21,060 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (10,322 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (13,449 underlying)
North Bridge Venture Management V, L.P.
10% Owner
Holdings

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (10,322 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (50,027 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (15,717 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (88,500 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (56,519 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (94,849 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (46,489 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (133,039 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (84,963 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (108,614 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (53,236 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (33,572 underlying)

  • Series A-1/A Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (16,455 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (32,066 underlying)

  • Series A-1/B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (47,783 underlying)

  • Series A-1/C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (43,377 underlying)

  • Series A-3 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (65,208 underlying)

  • Series A-4 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (69,364 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (90,613 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (44,413 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (70,200 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (34,408 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (21,060 underlying)

  • Series A-2 Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (60,573 underlying)

  • Series B Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (57,868 underlying)

  • Series C Convertible Preferred Stock

    (indirect: See footnote)
    → Common Stock (44,832 underlying)

  • Common Warrants

    (indirect: See footnote)
    Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (13,449 underlying)
Footnotes (4)
  • [F1]The preferred stock is convertible at any time, at the holder's election and has no expiration date. Each share of preferred stock shall be automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering.
  • [F2]The reportable securities are owned directly by North Bridge Venture Partners V-A, L.P. ("NBVP V-A"). North Bridge Venture Management V, L.P. ("NBVM V") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC ("NBVM GP") is the sole general partner of NBVM V. Each of Edward T. Anderson ("Anderson"), a member of the Issuer's board of directors, and Richard A. D'Amore ("D'Amore") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
  • [F3]The reportable securities are owned directly by North Bridge Venture Partners V-B, L.P. ("NBVP V-B"). NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
  • [F4]The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Documents

1 file

Issuer

Lyra Therapeutics, Inc.

CIK 0001327273

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001401650

Filing Metadata

Form type
3
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 7:23 PM ET
Size
47.7 KB
View on SEC.gov